A healthcare provider will need to determine if your dose of topiramate needs adjustment or if the timing of your dose should be shifted
Secondary outcome measures were acute myocardial infarction (ICD-10: I21), stroke (cerebral infarction or nontraumatic intracerebral hemorrhage) (ICD-10: I61, I63), or acute heart failure (ICD-10: I50.21, I50.23, I50.31, I50.33, I50.41, I50.43, I50.811, I50.813)
GLP-1 receptor agonists (semaglutide, liraglutide) increase gallbladder event rates compared to placebo, primarily due to rapid weight loss rather than the medication itself
Farooqi, "Role of melanocortin signalling in the preference for dietary macronutrients in human beings," Lancet Lond
When appetite is strongly suppressed, particularly after a dose increase, many women find they genuinely do not feel hungry at their usual meal times and simply don't eat